Latest Breaking News On - Immune thrombocytopenia - Page 1 : comparemela.com

Lifeline partners with family, hosts "Give for Graham" blood drive

One local family is inviting the public out to give towards a cause close to their heart.

Beth-ann
Graham-simpson
Melinda-reid
Beth-ann-simpson
Adam-simpson
Immune-thrombocytopenia
Graham-blood-drive

HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress

HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Spain
Ying-qian
Jiangxi
China
Madrid
Tianjin
Texas
United-states
Shanghai
Wuhan
Hubei
Norway

HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress

HONG KONG, SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 HUTCHMED Limited today announces that topline and subgroup results from the ESLIM-01 Phase III study of sovleplenib, as well as new.

Beijing
China
Spain
Tianjin
Shanghai
Oslo
Norway
Wuhan
Hubei
Ying-qian
Jiangxi
Valencia

HUTCHMED Data to be Presented at EHA2024 Congress | Company Announcement

Investegate announcements from HUTCHMED Data to be Presented at EHA2024 Congress

Spain
Cheng-mei
Guangdong
China
Oslo
Norway
Hong-kong
Tianjin
Houston
Texas
United-states
Beijing

CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP)

CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP)
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Wuxi
Jiangsu
China
Beijing
United-states
Rui-zhang
Pharmaceuticals-wuxi-co-ltd
Exchange-commission
Pharmaceuticals-china-co-ltd
Drug-administration
European-medicines-agency
Pharmaceuticals-inc

Latest Breaking News On - Immune thrombocytopenia - Page 1 : comparemela.com

Lifeline partners with family, hosts "Give for Graham" blood drive

One local family is inviting the public out to give towards a cause close to their heart.Beth-annGraham-simpsonMelinda-reidBeth-ann-simpsonAdam-simpsonImmune-thrombocytopeniaGraham-blood-drive

HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress

HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress

HONG KONG, SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 HUTCHMED Limited today announces that topline and subgroup results from the ESLIM-01 Phase III study of sovleplenib, as well as new.BeijingChinaSpainTianjinShanghaiOsloNorwayWuhanHubeiYing-qianJiangxiValencia

HUTCHMED Data to be Presented at EHA2024 Congress | Company Announcement

Investegate announcements from HUTCHMED Data to be Presented at EHA2024 CongressSpainCheng-meiGuangdongChinaOsloNorwayHong-kongTianjinHoustonTexasUnited-statesBeijing

CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP)

One local family is inviting the public out to give towards a cause close to their heart.

Beth-ann
Graham-simpson
Melinda-reid
Beth-ann-simpson
Adam-simpson
Immune-thrombocytopenia
Graham-blood-drive

HONG KONG, SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 HUTCHMED Limited today announces that topline and subgroup results from the ESLIM-01 Phase III study of sovleplenib, as well as new.

Beijing
China
Spain
Tianjin
Shanghai
Oslo
Norway
Wuhan
Hubei
Ying-qian
Jiangxi
Valencia

Investegate announcements from HUTCHMED Data to be Presented at EHA2024 Congress

Spain
Cheng-mei
Guangdong
China
Oslo
Norway
Hong-kong
Tianjin
Houston
Texas
United-states
Beijing